44 FAS gene expression is epigenetically regulated and predicts the responsiveness to azacitidine in high-risk myelodysplastic syndromes

44 FAS gene expression is epigenetically regulated and predicts the responsiveness to azacitidine in high-risk myelodysplastic syndromes S. Ettou, C. Humbrecht, B. Benet, O. Kosmider, N. Droin, O. Beyne-Rauzy, B. Quesnel, C. Lacombe, F. Dreyfus, P. Mayeux, E. Solary, M. Fontenay. Inserm U1016 CNRS UMR 8104, University Paris 5, Faculty of Medicine Rene Descartes, Cochin Institute, Hematology Department, Paris, France; APHP, Service d’Hematologie biologique, Hopital Cochin, Paris, Inserm UMR 1009, Institut Gustave Rousy, Villejuif, Hopital Purpan, Toulouse, Service des maladies du Sang, CHRU, Lille, France